or Try an Advanced Search...

    Technical Analysis for ASLN - ASLAN Pharmaceuticals Limited

    Grade Last Price % Change Price Change
    F 0.40 0.00% 0.00
    ASLN closed unchanged on Wednesday, May 15, 2024, on 9 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ASLN trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -1.48%
    Older End-of-Day Signals for ASLN ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 16 hours ago
    Up 3% about 16 hours ago
    Up 2% about 16 hours ago
    Up 1% about 16 hours ago
    Up 3% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ASLN Chart by TradingView
    Basic chart:

    Profile

    ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Cyclacel

    Is ASLN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
    May 2 ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
    Apr 24 ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
    Apr 22 ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
    Apr 19 ASLAN Pharmaceuticals announces receipt of Nasdaq notice
    Apr 19 ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
    Apr 12 ASLAN Pharmaceuticals GAAP EPADS of -$0.78
    Apr 12 ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    Apr 9 Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
    Mar 27 Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
    See more ASLN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.4
    52 Week Low 0.392
    Average Volume 1,470,919
    200-Day Moving Average 1.01
    50-Day Moving Average 0.56
    20-Day Moving Average 0.44
    10-Day Moving Average 0.42
    Average True Range 0.05
    RSI (14) 38.65
    ADX 17.46
    +DI 13.76
    -DI 17.86
    Chandelier Exit (Long, 3 ATRs) 0.45
    Chandelier Exit (Short, 3 ATRs) 0.56
    Upper Bollinger Bands 0.52
    Lower Bollinger Band 0.37
    Percent B (%b) 0.21
    BandWidth 33.21
    MACD Line -0.04
    MACD Signal Line -0.04
    MACD Histogram 0.0016
    Fundamentals Value
    Market Cap 6.67 Million
    Num Shares 16.7 Million
    EPS -3.00
    Price-to-Earnings (P/E) Ratio -0.13
    Price-to-Sales 0.78
    Price-to-Book 2.14
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.43
    Resistance 3 (R3) 0.43 0.43 0.43
    Resistance 2 (R2) 0.43 0.42 0.43 0.42
    Resistance 1 (R1) 0.41 0.41 0.41 0.41 0.42
    Pivot Point 0.41 0.41 0.41 0.41 0.41
    Support 1 (S1) 0.39 0.40 0.39 0.39 0.38
    Support 2 (S2) 0.39 0.39 0.39 0.38
    Support 3 (S3) 0.37 0.39 0.38
    Support 4 (S4) 0.37